<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Dangerous substances and preparations C/M/R - Thursday, 10 April 2003</title><meta name="title" content="Verbatim report of proceedings - Dangerous substances and preparations C/M/R - Thursday, 10 April 2003" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2003 - Source: European Parliament" /><meta name="available" content="10-04-2003" /><meta name="sipade-leg" content="5" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Dangerous substances and preparations C/M/R - Thursday, 10 April 2003" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-5-2003-04-10-ITM-002_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li class="bg" title="bg - български">bg - български</li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_ES.html">es - español</a></li>
            <li class="cs" title="cs - čeština">cs - čeština</li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_DE.html">de - Deutsch</a></li>
            <li class="et" title="et - eesti keel">et - eesti keel</li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li class="hr" title="hr - hrvatski">hr - hrvatski</li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_IT.html">it - italiano</a></li>
            <li class="lv" title="lv - latviešu valoda">lv - latviešu valoda</li>
            <li class="lt" title="lt - lietuvių kalba">lt - lietuvių kalba</li>
            <li class="hu" title="hu - magyar">hu - magyar</li>
            <li class="mt" title="mt - Malti">mt - Malti</li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_NL.html">nl - Nederlands</a></li>
            <li class="pl" title="pl - polski">pl - polski</li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_PT.html">pt - português</a></li>
            <li class="ro" title="ro - română">ro - română</li>
            <li class="sk" title="sk - slovenčina">sk - slovenčina</li>
            <li class="sl" title="sl - slovenščina">sl - slovenščina</li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-5-2003-04-10-ITM-002_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2003-04-10-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2003-04-10-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2003-04-10-ITM-001_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2003-04-10-ITM-001_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-5-2003-04-10-ITM-003_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-5-2003-04-10-ITM-003_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-5-2003-04-10_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-5-2003-04-10_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table><table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 10 April 2003 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">OJ edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 2. Dangerous substances and preparations C/M/R</td></tr></table>
<a name="4-030"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1838.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President. – </span></span>  The next item is the recommendation for second reading (<a href="/doceo/document/A-5-2003-0099_EN.html">A5-0099/2003</a>), on behalf of the Committee on the Environment, Public Health and Consumer Policy, on the Council common position for adopting a European Parliament and Council Directive amending, for the twenty-fifth time, Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogens, mutagens or substances toxic to reproduction – c/m/r) [15703/2/2002 – C5-0013/2003 et 15703/2/2002.REV 2 COR 1 – C5-0013/2003/COR – <a href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2002/0040(COD)">2002/0040(COD)</a>] (rapporteur: Mrs Schörling). </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-031"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2267.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Schörling (Verts/ALE), </span></span>  <span class="italic">rapporteur.</span> <span class="italic">(SV)</span> Mr President, Commissioner, ladies and gentlemen, this draft Directive seeks to amend for the twenty-fifth time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations. Existing chemicals legislation states that, as soon as a substance or preparation has been classified as carcinogenic, mutagenic or toxic to reproduction, it must be included in this annex and not released onto the market. This proposal applies to 44 new substances which must be added to this list. I believe we are all agreed that that is a very good thing that this be done and that we must of course adopt the proposal to add these substances.</p>
<p class="contents">When Parliament debated this matter for the first time, we considered that there were two deficiencies in existing legislation that we very much wanted to remedy. We believed that we did not need to wait for the new chemicals legislation and wanted, for the sake of public health, to make amendments more promptly.</p>
<p class="contents">The first deficiency was that the use in consumer articles of CMR substances – carcinogens, mutagens or substances toxic to reproduction – was not prohibited. Articles of this kind include flooring, toys and textiles such as we come into contact with every day as consumers and which cause us genuinely to become exposed to these chemical compounds. We therefore wanted a ban. The second deficiency led to our naturally wanting a ban on the use of CMR products in cosmetics.</p>
<p class="contents">The Council has since rejected Parliament’s amendments. Where cosmetic products are concerned, our proposal has however been accepted. At a conciliation, it was agreed to ban category 1 and category 2 CMR substances in the cosmetics directive when the seventh amendment was made. It can therefore be stated that Parliament’s proposal concerning cosmetic products has been accepted.</p>
<p class="contents">When it came to consumer articles, there were three main reasons why the Council wanted to reject Parliament’s amendments. Firstly, it believed that there were no relevant scientific evaluations or risk assessments. In fact, risk assessments have actually been carried out. There has also been a proposal from the Commission to the effect that, since the use of chemicals by consumers cannot be controlled, safety can only be ensured by prohibiting the general use of substances and preparations that are carcinogenic, mutagenic or toxic to reproduction.</p>
<p class="contents">In the committee’s and my own view, there is no reason not to make the same assessment in connection with the use of consumer articles. The argument does not, then, hang together in this respect.</p>
<p class="contents">Secondly, the Council referred to the fact that we are concerned here with a very large and unspecified number of products. As I see it, that is a completely baffling argument. It should be exactly the other way around. If there are now so many products containing, for example, carcinogenic substances, there is surely genuine reason to take action instead of merely saying that, because there are such a lot of products, nothing can be done.</p>
<p class="contents">Thirdly, the Council stated that this issue will be addressed in the context of developing the new chemicals policy. That is very commendable, and I am really pleased about it. I believe that the proposal it may be possible to put before Parliament some time in June concerning the new chemicals legislation will also take these products into account. It will, however, take a very long time before that legislation comes into force, so it would have been helpful to have obtained this amendment at the present stage.</p>
<p class="contents">Now, at second reading, it might have been imagined that we should have tabled the same amendment. I have chosen, however, not to do so, and my colleagues in the committee were of the same view. We brought debate of this matter to a head when the twenty-third amendment was adopted following Mr Nisticò’s report. The same debate was conducted then, and it did not actually lead to anything. I have therefore chosen to recommend to Parliament that, on the grounds that we have had our proposals concerning cosmetic products accepted, it adopt this second-reading recommendation concerning the Council’s common position. We have come to the end of the road where the proposals relating to the second type of product are concerned. We must accept matters as they stand. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-032"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Liikanen,</span></span>   <span class="italic">Commission</span>. – Mr President, first of all I would like to thank the Committee on the Environment, Public Health and Consumer Policy, and in particular its rapporteur, Mrs Schörling, for her very constructive handling of this proposal. The aims of the proposed directive are to guarantee the free movement of chemical substances and preparations and to improve health protection and consumer safety by prohibiting the placing of CMR substances on the market for use by the general public. The proposed directive will accordingly introduce harmonised rules throughout the Community.</p>
<p class="contents">On 12 February 2002 the Commission proposed a directive which would update the existing list of CMR substances banned for consumer use by adding 44 further substances. By covering substances and preparations (such as glues, household cleaning products and paints) the Commission's proposal addresses the situations most likely to lead to exposure of consumers. This is the fifth time that the Commission has proposed such an update of the list of CMR substances. If risks of CMR substances in articles are identified, such uses are restricted separately on a case-by-case basis founded on risk assessment.</p>
<p class="contents">To conclude, the Commission believes that its proposal not only provides for the protection of consumers' health, but also preserves the internal market by the introduction of harmonised rules. I would therefore ask for your support for the adoption of this important measure. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-033"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1321.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bowe (PSE).</span></span>   – Mr President, on behalf of the Socialist Group, I welcome and support this proposal.</p>
<p class="contents">It is a step forward that 44 new substances recognised as CMRs have been added to the list of banned substances and are going to be removed from products and other uses within the Union. It is certainly a step forward in the protection of human health.</p>
<p class="contents">The question of cosmetics now appears to have been resolved and we can express ourselves satisfied with that agreement. Again, that is a significant step forward for the health of cosmetics users.</p>
<p class="contents">As regards the question of chemicals in products, I accept the view expressed in Parliament's report that we should start to look very closely at this issue. However, I agree with the Commission that this issue has much wider implications than simply controlling 44 chemicals in our existing proposal and their potential dangers. It is now clear that this issue is going to be addressed in the new forthcoming chemicals policy. We can therefore express ourselves satisfied that we have made good progress on this proposal and we can look to pick up the issue of chemicals in products, and a range of other issues, when we address the chemicals policy proposal that we understand the Commission will be publishing for wider consultation on 7 May. I expect we can start work on that in the autumn of this year.</p>
<p class="contents">Therefore, on behalf of the Socialist Group, I commend this proposal and its results to the House and look forward to continuing our constructive dialogue and work with the Commission. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-034"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1838.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">President. – </span></span>  Thank you, Mr Bowe.</p>
<p class="contents">The debate is closed.</p>
<p class="contents">The vote will take place at 12 noon. </p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
